Healthcare / Medical Care FacilitiesBSE
$135.35
+0.80 (+0.59%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-46.4M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
52/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$10.7B
P/E
62.7x
↑EV/EBITDA
30.9x
↑ROE
6.1%
↑Gross Margin
88.9%
↑Debt/Equity
0.12
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
-1.5%
FCF CAGR
—
FCF margin
-191.8%
FCF / Net income
-10.15x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $820.1M · net income $155.0M · FCF $-1.57B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $820.1M | $820.1M | $402.4M | $1.03B | $857.9M |
| Net Income | $155.0M | $155.0M | $94.1M | $96.8M | $66.4M |
| EBITDA | $278.1M | $278.1M | $167.0M | $220.3M | $179.3M |
| EPS | 2.49 | 2.49 | 1.19 | 1.23 | 0.84 |
| Gross Margin | 88.9% | 88.9% | 90.2% | 89.2% | 88.6% |
| Operating Margin | 27.1% | 27.1% | 32.9% | 14.3% | 13.5% |
| Net Margin | 18.9% | 18.9% | 23.4% | 9.4% | 7.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.12 | 0.12 | 0.59 | 1.23 | 1.06 |
| Current Ratio | 3.76 | 3.76 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-1.57B | $-1.57B | $-46.4M | $12.1M | $1000.00 |
| Returns | |||||
| ROE | 6.1% | 6.1% | 24.4% | 43.5% | 30.2% |
| Valuation | |||||
| P/E | 62.66 | 62.66 | — | — | — |
| EV/EBITDA | 30.86 | 30.86 | — | — | — |
| P/B | 3.34 | 3.34 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 103.8% | 103.8% | -61.1% | 20.6% | — |
| EPS Growth | 108.6% | 108.6% | -2.8% | 45.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
69.0%
EPS terminal req.
$12.01
Spread vs growth
39.6%
5Y implied EPS CAGR
42.3%
EPS terminal req.
$14.53
Spread vs growth
66.3%
10Y implied EPS CAGR
25.1%
EPS terminal req.
$23.40
Spread vs growth
83.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+31.4%
Start / end P/E
87.7x → 55.2x
EPS bridge
1.19 → 2.49
Residual
-40.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.